An S - Search Results

1

PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity.

Park CH, Rha SY, Ahn JB, Shin SJ, Kwon WS, Kim TS, An S, Kim NK, Yang WI, Chung HC. Park CH, et al. Among authors: an s. Int J Cancer. 2015 May 15;136(10):2273-83. doi: 10.1002/ijc.29273. Epub 2014 Oct 30. Int J Cancer. 2015. PMID: 25346044

2

Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray.

Yang SH, Kim JS, Oh TJ, Kim MS, Lee SW, Woo SK, Cho HS, Choi YH, Kim YH, Rha SY, Chung HC, An SW. Yang SH, et al. Int J Oncol. 2003 Apr;22(4):741-50. Int J Oncol. 2003. PMID: 12632063

3

Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.

Yeo M, Rha SY, Jeung HC, Hu SX, Yang SH, Kim YS, An SW, Chung HC. Yeo M, et al. Int J Cancer. 2005 Apr 10;114(3):484-9. doi: 10.1002/ijc.20720. Int J Cancer. 2005. PMID: 15551309

4

Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.

Ji HJ, Rha SY, Jeung HC, Yang SH, An SW, Chung HC. Ji HJ, et al. Breast Cancer Res Treat. 2005 Oct;93(3):227-36. doi: 10.1007/s10549-005-5156-0. Breast Cancer Res Treat. 2005. PMID: 16132531

5

Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer.

Rha SY, Jeung HC, Yang WI, Kim JJ, Oh TJ, An SW, Chung HC. Rha SY, et al. Oncol Rep. 2006 Apr;15(4):749-55. Oncol Rep. 2006. PMID: 16525654

6

Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.

An SW, Kim NK, Chung HC. An SW, et al. Yonsei Med J. 2009 Jun 30;50(3):331-4. doi: 10.3349/ymj.2009.50.3.331. Epub 2009 Jun 23. Yonsei Med J. 2009. PMID: 19568592 Free PMC article. Review.

7

Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer.

Jung S, Jeong D, Kim J, Yi L, Koo K, Lee J, Kim CJ, Kim CH, An S, Yang Y, Lim JS, Kim KI, Lee MS. Jung S, et al. Among authors: an s. Int J Oncol. 2011 Mar;38(3):859-69. doi: 10.3892/ijo.2011.904. Epub 2011 Jan 14. Int J Oncol. 2011. PMID: 21240459

8

Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.

Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, Kim TS, Kim NK, Chung HC, An S. Oh T, et al. Among authors: an s. J Mol Diagn. 2013 Jul;15(4):498-507. doi: 10.1016/j.jmoldx.2013.03.004. Epub 2013 Jun 7. J Mol Diagn. 2013. PMID: 23747112 Free article.

9

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer.

Oh TJ, Oh HI, Seo YY, Jeong D, Kim C, Kang HW, Han YD, Chung HC, Kim NK, An S. Oh TJ, et al. Among authors: an s. Clin Epigenetics. 2017 Dec 4;9:126. doi: 10.1186/s13148-017-0426-3. eCollection 2017. Clin Epigenetics. 2017. PMID: 29225717 Free PMC article.

10

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.

Han YD, Oh TJ, Chung TH, Jang HW, Kim YN, An S, Kim NK. Han YD, et al. Among authors: an s. Clin Epigenetics. 2019 Mar 15;11(1):51. doi: 10.1186/s13148-019-0642-0. Clin Epigenetics. 2019. PMID: 30876480 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,350 results

Search Page

Filters